GeminIQ Website Logo

Viewing BMY free

Subscribe for full history, 50+ metrics, screener, watchlist...

BRISTOL MYERS SQUIBB CO

BMY

Companies in Pharmaceutical Preparations

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Cash And Cash Equivalents At Carrying Value
9,57410,20915,72612,59910,87510,3467,8906,2939,33011,4647,5148,372
Marketable Securities Current
----------171358
Available For Sale Securities Debt Securities Curr…
9124647761,004907513204360340816--
Receivables Net Current
9,36811,41411,42211,41510,80110,74711,02611,42310,44710,92110,30410,112
Assets Current
Assets Current
27,20829,39035,63033,22230,78329,78028,07526,89028,66931,77027,63228,074
Inventory Net
2,7562,6902,7582,7372,6662,5573,3323,0772,9852,6622,4362,364
Other Assets Current
4,5974,6134,9485,4665,5345,6175,6235,7375,5675,9077,2076,868
Property Plant And Equipment Net
7,6587,5437,3497,3737,2137,1366,9036,8456,7506,6466,4816,355
Goodwill
21,74021,75421,74521,77621,73721,71921,75121,73221,73821,16921,14721,163
Intangible Assets Net Excluding Goodwill
18,24419,10320,46521,37822,48623,30726,96429,42832,76027,07228,95031,303
Deferred Income Tax Assets Net
5,1765,3784,9614,6473,9974,2363,6093,3232,7232,7681,5141,572
Marketable Securities
----------325-
Available For Sale Securities Debt Securities Nonc…
366396406346344320324357367364--
Other Assets Noncurrent
6,0826,4746,3325,9365,8666,1056,0446,0716,0245,3705,2145,022
Assets
86,47690,03896,88994,67692,42792,60393,67094,64699,03195,15991,26393,489
Liabilities
Debt Current
2,3082,2614,5094,7153,5542,0461,0783,5316,1903,1195,4673,020
Accounts Payable Current
4,2343,5754,2885,4274,0023,6023,4693,7513,5393,2592,8133,069
Liabilities Current
Liabilities Current
19,15823,41728,13627,52824,07023,77422,63823,26525,82222,26223,46220,150
Other Liabilities Current
12,61617,58119,33917,38616,51418,12618,09115,98316,09315,88415,18214,061
Deferred Income Tax Liabilities Net
211222225247276369430461442338399751
Long Term Debt Noncurrent
42,15242,85044,46944,47046,15747,60348,67448,85849,48736,65332,13734,656
Other Liabilities Noncurrent
4,8535,0435,4594,9424,4774,4694,7284,9936,7326,4216,2035,902
Liabilities
66,37471,53378,28977,18774,97976,21576,47077,57782,48365,67462,20161,459
Stockholders Equity Inclu…
Preferred Stock Value
000000000000
Common Stock Value Outstanding
292292292292292292292292292292292292
Additional Paid In Capital
46,37446,38746,26546,13446,01146,02445,89645,76645,65545,68444,84945,299
Stockholders Equity
Stockholders Equity
20,06818,47318,55217,43517,44816,38817,20017,01516,54829,48528,99831,973
Accumulated Other Comprehensive Income Loss Net Of…
-1,370-1,524-1,513-1,554-1,424-1,238-1,468-1,456-1,400-1,546-1,286-1,387
Retained Earnings Accumulated Deficit
18,28716,89617,09316,15416,10614,91216,09716,10315,64028,76628,21827,449
Treasury Stock Common Value
-43,515-43,579-43,586-43,590-43,597-43,655-43,675-43,690-43,697-43,766-43,075-39,680
Minority Interest
343348545953585458556457
Liabilities And Stockholders Equity
86,47690,03896,88994,67692,42792,60393,67094,64699,03195,15991,26393,489
Preferred Stock Dividend Rate Per Dollar Amount
-0---0---0--
Preferred Stock Par Or Stated Value Per Share
-1---1---1--
Preferred Stock Shares Authorized
-10---10---10--
Preferred Stock Shares Issued
-0---0---0--
Preferred Stock Shares Outstanding
-0---0---0--
Preferred Stock Liquidation Preference Value
-50---50---50--
Common Stock Par Or Stated Value Per Share
-0.1---0.1---0.1--
Common Stock Shares Authorized
-4,500---4,500---4,500--
Common Stock Shares Issued
-2,900---2,900---2,900--
Treasury Stock Common Shares
-887---894---902--

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-1.86%-10.88%1.38%---------
2025-3.98%2.18%-2.49%10.64%3.95%2.12%1.38%18.79%22.56%0.60%0.47%-1.85%
2024-1.50%-7.83%-8.11%-2.16%-2.62%4.63%5.56%2.80%2.05%8.80%-0.45%-8.96%
2023---2.19%-2.80%-6.07%-4.02%-3.93%-3.92%10.43%6.58%-8.64%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
1.42
1.26
1.27
1.21
1.28
1.25
1.24
1.16
1.11
1.43
1.18
1.39
Quick Ratio
1.28
1.14
1.17
1.11
1.17
1.15
1.09
1.02
0.99
1.31
1.07
1.28
Working Capital
8.05B
5.97B
7.49B
5.69B
6.71B
6.01B
5.44B
3.63B
2.85B
9.51B
4.17B
7.92B
Leverage & Debt
Debt to Equity
3.31
3.87
4.22
4.43
4.30
4.65
4.45
4.56
4.98
2.23
2.15
1.92
Debt Ratio
0.77
0.79
0.81
0.82
0.81
0.82
0.82
0.82
0.83
0.69
0.68
0.66
Efficiency & Turnover
Asset Turnover TTM
0.54
0.53
0.50
0.50
0.50
0.51
0.51
0.49
0.47
0.47
0.47
0.47
Days Sales Outstanding TTM
75.92
83.92
85.29
87.37
81.40
81.87
82.06
84.50
82.17
84.37
80.89
77.41
Receivables Turnover TTM
4.81
4.35
4.28
4.18
4.48
4.46
4.45
4.32
4.44
4.33
4.51
4.72
Per Share Metrics
Diluted EPS TTM
3.55
3.46
2.96
2.48
2.66
-4.41
-3.57
-3.22
-3.04
3.86
4.02
3.80
Free Cash Flow Per Share TTM
5.84
6.32
7.52
7.16
6.44
6.88
6.81
6.39
6.18
6.11
5.68
5.12
Dividend Per Share TTM
2.49
2.48
2.46
2.43
2.42
2.40
2.37
2.36
2.35
2.29
2.30
2.24
Margin Metrics
Gross Profit Margin TTM
70.46%
71.08%
69.50%
70.29%
70.47%
71.08%
74.91%
75.38%
75.71%
76.24%
76.54%
77.01%
Operating Profit Margin TTM
19.79%
19.36%
16.72%
13.82%
12.82%
-17.35%
-14.50%
-13.80%
-12.84%
18.75%
19.19%
19.25%
Net Profit Margin TTM
15.00%
14.64%
12.57%
10.59%
11.39%
-18.53%
-15.30%
-14.06%
-13.50%
17.83%
18.49%
17.67%
Growth Metrics
Net Revenue Growth (1Y)
1.78%
-0.22%
1.26%
2.57%
4.62%
7.32%
5.56%
2.93%
-0.68%
-2.50%
-3.86%
-4.15%
Net Income Growth (1Y)
34.03%
-178.84%
-183.19%
-177.27%
-188.24%
-211.50%
-187.37%
-181.92%
-183.89%
26.48%
24.26%
20.42%
EPS Growth (1Y)
33.57%
-178.57%
-182.86%
-176.96%
-187.89%
-213.81%
-188.62%
-184.58%
-187.04%
30.21%
28.85%
22.72%
Valuation Metrics
P/E TTM
16.64
15.04
14.51
17.55
21.27
-11.81
-13.17
-11.55
-15.83
11.60
12.48
14.43
P/B TTM
6.03
5.75
4.72
5.09
6.61
6.45
5.56
4.44
5.88
3.16
3.58
3.60
P/S TTM
2.50
2.20
1.82
1.86
2.42
2.19
2.02
1.62
2.14
2.07
2.31
2.55
Market Cap
120.98B
106.13B
87.62B
88.72B
115.41B
105.65B
95.62B
75.57B
97.35B
93.12B
103.67B
115.20B
Enterprise Value
155.85B
141.02B
120.87B
125.29B
154.24B
144.95B
137.48B
121.66B
143.69B
121.37B
133.71B
144.45B
Calculated Values
Free Cash Flow TTM
11.91B
12.85B
15.30B
14.58B
13.09B
13.94B
13.80B
12.95B
12.51B
12.65B
11.69B
10.72B
Net Debt
34.88B
34.89B
33.25B
36.57B
38.84B
39.30B
41.86B
46.09B
46.34B
28.25B
30.04B
29.25B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-04-01Sale
Owner: Elkins, David V
Title: EVP, Chief Financial Officer
Shares: 30,000
Price/Share: $61.82
Value: $1,854,600.00
Shares Owned: 159,248
Relationship: Officer
Ownership: Direct
2025-09-02Sale
Owner: Elkins, David V
Title: EVP, Chief Financial Officer
Shares: 56,000
Price/Share: $47.33
Value: $2,650,480.00
Shares Owned: 167,379
Relationship: Officer
Ownership: Direct
2025-08-02Sale
Owner: Short, Bartie Wendy
Title: EVP, Corporate Affairs
Shares: 378
Price/Share: $44.23
Value: $16,718.94
Shares Owned: 5,066
Relationship: Officer
Ownership: Direct
2025-05-09Sale
Owner: Hickey, Benjamin
Title: President, RayzeBio Org.
Shares: 97
Price/Share: $38.01
Value: $3,701.79
Shares Owned: -
Relationship: Officer
Ownership: Indirect
2025-04-25Purchase
Owner: Hirawat, Samit
Title: EVP,Chief Med.Offr.,Drug Dev.
Shares: 4,250
Price/Share: $47.58
Value: $202,215.00
Shares Owned: 83,513
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
70.44%
Inst. Shares: 1,435,643,223
Shares Outstanding: 2,038,000,000
2025-12-31
76.38%
Inst. Shares: 1,553,619,206
Shares Outstanding: 2,034,000,000
2025-09-30
74.40%
Inst. Shares: 1,514,785,863
Shares Outstanding: 2,036,000,000
2025-06-30
77.00%
Inst. Shares: 1,566,889,783
Shares Outstanding: 2,035,000,000
2025-03-31
75.02%
Inst. Shares: 1,523,659,112
Shares Outstanding: 2,031,000,000

BRISTOL MYERS SQUIBB CO (BMY) — SEC Financial Statements & Analysis

BRISTOL MYERS SQUIBB CO (BMY) is a pharmaceutical preparations company, incorporated in DE. BRISTOL MYERS SQUIBB CO trades on CELG-RI: NYSE as: BMY: NYSE. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), BRISTOL MYERS SQUIBB CO reported a 1.78% year-over-year revenue growth, a Gross Profit Margin of 70.46% (TTM), a Debt-to-Equity ratio of 3.31x, a Price-to-Sales (P/S) ratio of 2.50x (TTM), a Price-to-Book (P/B) ratio of 6.03 (TTM), at a market cap of $120.98B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
1.78%
Gross Profit Margin TTM
70.46%
Debt To Equity
3.31x
P/S TTM
2.50x
P/B TTM
6.03
Market Cap
$120.98B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is BRISTOL MYERS SQUIBB CO in?

BRISTOL MYERS SQUIBB CO (BMY) operates in the Pharmaceutical Preparations industry.

What is BMY's market cap?

BRISTOL MYERS SQUIBB CO (BMY) has a market capitalization of $120.98B as of 2026-03-31.

What is BMY's P/E ratio?

BRISTOL MYERS SQUIBB CO (BMY)'s trailing twelve month P/E ratio is 16.64x as of 2026-03-31.

What exchange does BMY trade on?

BRISTOL MYERS SQUIBB CO (BMY) trades on the CELG-RI: NYSE.

Where is BRISTOL MYERS SQUIBB CO incorporated?

BRISTOL MYERS SQUIBB CO is incorporated in DE.

Research Faster.
Invest Smarter.

BRISTOL MYERS SQUIBB CO (BMY) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.